Premorbid body mass index and risk of amyotrophic lateral sclerosis - Wikidata - wikimedia - TriplyDB

Premorbid body mass index and risk of amyotrophic lateral sclerosis

Premorbid body mass index and risk of amyotrophic lateral sclerosis

http://www.wikidata.org/entity/Q36737158

about

From animal models to human disease: a genetic approach for personalized medicine in ALS Risk factors for amyotrophic lateral sclerosis Physical Trauma and Amyotrophic Lateral Sclerosis: A Population-Based Study Using Danish National Registries Different occupations associated with amyotrophic lateral sclerosis: is diesel exhaust the link?Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study Motor neuron disease mortality rates in U.S. states are associated with well water use No association between biopsy-verified celiac disease and subsequent amyotrophic lateral sclerosis--a population-based cohort study.Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis - results from a population- based ALS registry in Germany.Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis.Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial The epidemiology of ALS: a conspiracy of genes, environment and time.Antecedent Disease is Less Prevalent in Amyotrophic Lateral Sclerosis.Association between diabetes and amyotrophic lateral sclerosis in Sweden.Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.Early-onset alopecia and amyotrophic lateral sclerosis: a cohort study High-fat and ketogenic diets in amyotrophic lateral sclerosis.AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis.Physical and cognitive fitness in young adulthood and risk of amyotrophic lateral sclerosis at an early age.Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments Assessment and nutrition education in patients with amyotrophic lateral sclerosis.Association Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis.Anthropometry of Arm: Nutritional Risk Indicator in Amyotrophic Lateral Sclerosis.Serum urate at trial entry and ALS progression in EMPOWER.Cardiovascular disease and diagnosis of amyotrophic lateral sclerosis: A population based study.Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival.Genetic induction of hypometabolism by ablation of MC4R does not suppress ALS-like phenotypes in the G93A mutant SOD1 mouse model.Prior medical conditions and the risk of amyotrophic lateral sclerosis.What is "Hyper" in the ALS Hypermetabolism?Nutritional assessment of amyotrophic lateral sclerosis in routine practice: value of weighing and bioelectrical impedance analysis.Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans.Motoneuron Disease: Clinical.Risk factors in Swedish young men for amyotrophic lateral sclerosis in adulthood.Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis.The Influence of Adipose Tissue on Brain Development, Cognition, and Risk of Neurodegenerative Disorders.The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis.Cardiometabolic health and risk of amyotrophic lateral sclerosis.

P2860

Q26741250-11F9733A-76F9-4AC7-9049-8869D36510EA Q26827642-4F385D13-7A70-422D-B99B-30AC77F0D030 Q28386898-AD583BCA-3735-47A6-BE94-DFDAFF5840D2 Q28390814-B9D441D8-44C0-4C71-B2C4-7295F38128B5 Q28391291-CA191ACE-44AB-4104-BA6E-14C0D52DAFB6 Q28396272-42479138-184C-4BF9-8825-46BD888AA3FB Q33754218-6E2F8863-04A5-42D6-A121-36B99CB1E00F Q33854270-5B65A2C9-D6CE-421C-84E7-B7AACBCE19CF Q34160767-1E78C915-9B4F-4E23-88A9-2E089DD66D27 Q34251334-51FEC3B9-B441-461F-ADA3-0822E8BA90B7 Q34377698-28BE1A3B-2571-4AED-BF05-431351845CC9 Q35561543-C6ACF91D-F8BF-45C1-B382-BABEEDC1711E Q35864714-9953692D-6F77-49EC-ACE3-2E9F8CE91482 Q35952241-5E44FB8E-4AC0-499D-A394-194878FFBF2B Q36735465-AD1C4CC4-3C1C-4F78-9DB5-5F131250A8CC Q37155949-060C6D4E-272C-4E04-8832-06BB6F5F1A27 Q37197648-4BE220A7-9DAB-4A12-A068-2D7153507A41 Q38105917-F3C560D9-0DD1-4CAE-8B25-2FC9F793DEA5 Q38552413-C3B2FCE0-698E-4BEA-A9AA-4EC3033CAAA4 Q38577066-42A9D718-4C80-4421-82B1-084206DE68DC Q38779898-12FDFC93-3C1B-4D94-B84F-DDFC649DB2FA Q39101800-439503A2-31BD-42EA-9FD4-D2FFD7FA4E86 Q39143420-B5019D81-86C9-4660-B241-1024F1E9AE40 Q39254848-EA11A2DE-EC48-4DB9-95D7-F75A723A1409 Q40084958-58D1CDBD-EC98-4BED-81AC-4861100B896A Q40563709-6FB2CCEB-B0F5-44DB-BF60-D5DF31E812AF Q40642266-B690420D-6C9A-4AD0-B9E6-8B9B00E3F305 Q41531607-BA99652D-4AA1-472B-9327-A091FC7DA2CA Q41693587-C1FB1DA7-D68D-48CA-BF71-2E2499783AEA Q42377167-2C592D11-FD72-49F2-9205-E9E98E64298F Q42673812-00259397-4D16-40A8-A53B-5FD5CCFA570A Q42730688-E722E7CC-D843-4953-971E-06AAC90F03B8 Q43884348-82927212-D2FF-4ADF-8506-7D4E9D5176DB Q45326900-F21C129F-D2A1-4881-9399-C041B3E2D7A8 Q45869420-3378254D-1DA6-460F-BCFA-7C1167574128 Q47559952-97CCA668-6708-4B5C-B1EA-50198DA6A17D Q47764404-25BA4853-E6E4-430A-AC55-1A020552B98A Q48103379-C2DCCAC5-FA52-4CF6-AACB-51F531620A89 Q48331542-9A11207F-BC4B-4194-A9AF-734EA0C8AA7F Q48379805-1C6941C7-E736-4E20-9180-14AC76E4BD0E

P2860

Premorbid body mass index and risk of amyotrophic lateral sclerosis

http://www.wikidata.org/entity/Q36737158

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Premorbid body mass index and risk of amyotrophic lateral sclerosis

@ast

Premorbid body mass index and risk of amyotrophic lateral sclerosis

@en

type

label

Premorbid body mass index and risk of amyotrophic lateral sclerosis

@ast

Premorbid body mass index and risk of amyotrophic lateral sclerosis

@en

prefLabel

Premorbid body mass index and risk of amyotrophic lateral sclerosis

@ast

Premorbid body mass index and risk of amyotrophic lateral sclerosis

@en

P1433

Q36737158-A250708F-7461-470C-BAE4-59DC4E73C40C

P1476

Q36737158-BE9D61BA-7606-43DB-8A59-48E797412BB4

P2093

Q36737158-0073F3DB-544F-41CC-A62B-0DC2A7164A92

Q36737158-318A6C91-DDA9-43E3-9289-E8A1EF1B7840

Q36737158-4AB06AB2-54B9-495B-A52C-DCF119787E9A

Q36737158-5B38A727-105B-45F7-B83B-1C827EDFF1A7

Q36737158-674A082B-56E4-4D6A-87BA-7AA1D0305D34

Q36737158-C4802866-F927-493F-B39A-FF4044C3C8A1

Q36737158-F1F293D8-254A-4D43-B60B-7C49609D7BBE

Q36737158-F619B0DE-F391-4876-B68F-D8937C217070

P2860

Q36737158-0590CAB5-A5AE-46D3-8C33-73E9E3F035EA

Q36737158-0C71A8DD-F148-4782-9652-EA593173F078

Q36737158-1A94F4CC-B951-4004-BE43-902585E7BE6D

Q36737158-2643F861-1E4B-4E13-BBED-D9C988EC1FC1

Q36737158-2AF7783D-798D-432A-886F-00138865EA5C

Q36737158-2C9A1B7F-CD94-4A5C-B785-9D4FD65CB2B6

Q36737158-331A51B5-E33A-48A0-8FCF-1C80323BED13

Q36737158-524C5C03-72AE-484A-B8C0-586798A801AA

Q36737158-6AC3C1BA-E621-4D85-84ED-35C674F349F6

Q36737158-73CF765D-91A2-4460-87D5-DE84916FDA7E

P304

Q36737158-DA63BFF6-711D-4230-87A9-26972008C923

P31

Q36737158-E192D4A1-5701-421D-A984-D0840AEBD2D7

P356

Q36737158-3DA7A17C-22E1-4BBC-9DFB-0ED0F61C866C

P433

Q36737158-FE4E7385-BA39-449D-8668-F05D2BCCAB04

P478

Q36737158-9B370A30-C32B-4410-B7DD-25BDEEC4FC5A

P50

Q36737158-417D39CC-E94B-4561-B31D-A8FE1D5C2E32

Q36737158-8AD52529-0B6D-4526-9856-52E152DF5CEF

P577

Q36737158-B41248F3-7186-4F24-B0F4-6479DA96FD5C

P698

Q36737158-ACE769C4-F559-4FA2-9D70-8CA4435FFCCF

P921

Q36737158-F1E27073-6821-4F2B-8A85-9C4D88AEF9CB

P932

Q36737158-524A2856-0736-4A9C-87AA-1CEEABB5966E

P356

21678421.2012.735240

P1433

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

P1476

Premorbid body mass index and risk of amyotrophic lateral sclerosis

@en

P2093

Guido Falcone

http://www.w3.org/2001/XMLSchema#string

Hao Wang

http://www.w3.org/2001/XMLSchema#string

Kathryn C Fitzgerald

http://www.w3.org/2001/XMLSchema#string

Laurence N Kolonel

http://www.w3.org/2001/XMLSchema#string

Marc G Weisskopf

http://www.w3.org/2001/XMLSchema#string

Marjorie L McCullough

http://www.w3.org/2001/XMLSchema#string

Michael Thun

http://www.w3.org/2001/XMLSchema#string

Éilis J O'Reilly

http://www.w3.org/2001/XMLSchema#string

P2860

The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics

Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis

Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death.

A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics

Physical activity and the association with sporadic ALS.

Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.

Energy metabolism in amyotrophic lateral sclerosis.

Disease progression in amyotrophic lateral sclerosis: predictors of survival.

Prospective study of alcohol consumption and risk of coronary disease in men.

Hypotheses to explain the association between vigorous physical activity and amyotrophic lateral sclerosis.

P304

205-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/21678421.2012.735240

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Alberto Ascherio

P577

2012-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23134505

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

3615420

http://www.w3.org/2001/XMLSchema#string